3C
CHE icon

361 Capital’s Chemed CHE Stock Holding History

361 Capital’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,515
Closed -$1.96M – 316
2020
Q1 		$1.96M Sell
4,515
-1,322
-23% -$590K 0.89% 2
2019
Q4 		$2.56M Sell
5,837
-3,239
-36% -$1.36M 0.71% 1
2019
Q3 		$3.79M Sell
9,076
-2,914
-24% -$1.19M 0.7% 3
2019
Q2 		$4.33M Sell
11,990
-579
-5% -$194K 0.77% 1
2019
Q1 		$4.02M Sell
12,569
-1,218
-9% -$374K 0.7% 1
2018
Q4 		$3.91M Buy
13,787
+4,092
+42% +$1.23M 0.8% 1
2018
Q3 		$3.1M Buy
9,695
+3,946
+69% +$1.26M 0.67% 5
2018
Q2 		$1.85M Buy
5,749
+189
+3% +$59.1K 0.42% 56
2018
Q1 		$1.52M Sell
5,560
-4,096
-42% -$1.09M 0.38% 111
2017
Q4 		$2.35M Buy
9,656
+5,327
+123% +$1.21M 0.58% 50
2017
Q3 		$875K Buy
+4,329
New +$851K 0.17% 197

Other funds holding CHE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

361 Capital's CHE Position: Q2 2020 in Review

361 Capital sold out of Chemed (CHE) in Q2 2020, closing a stake of 4,515 shares — an estimated $1.96M sold.

361 Capital first reported a position in CHE in Q3 2017 and held it in 11 quarters. The position peaked at $4.33M in Q2 2019. 425 funds tracked by Wall St. Rank hold CHE as of Q2 2020.

  • 361 Capital reported no remaining Chemed position as of Q2 2020 after selling out during the quarter.
  • 361 Capital sold 4,515 Chemed shares in Q2 2020, an estimated $1.96M.
  • 361 Capital first reported a position in Chemed in Q3 2017 and held it in 11 quarters.
  • 361 Capital's Chemed position peaked at $4.33M in Q2 2019.
  • 425 funds tracked by Wall St. Rank held Chemed as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.